BMY Bristol-Myers Squibb Company
$58.34
Bristol-Myers Squibb Company (BMY) Earnings News
Earnings press releases, previews and reviews for Bristol-Myers Squibb Company (BMY), newest first. Our most recent is review: Bristol Myers Beats and Raises for a Third Straight Quarter, but Slowing Growth Drivers and the Eliquis Cliff Keep the Debate Alive.
Thursday
October 29, 2026
10:39 AM ET
Bristol Myers Beats and Raises for a Third Straight Quarter, but Slowing Growth Drivers and the Eliquis Cliff Keep the Debate Alive
Earnings Whispers · Review
Thursday
October 29, 2026
6:59 AM ET
Bristol Myers Squibb Reports Third Quarter Financial Results for 2026
Wednesday
October 21, 2026
11:22 AM ET
Bristol Myers Must Prove Its Guidance Raise Was Real as Eliquis Tailwind Arrives
Earnings Whispers · Preview
Friday
September 18, 2026
6:59 AM ET
Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026
Thursday
July 30, 2026
6:59 AM ET
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026
Thursday
June 18, 2026
6:59 AM ET
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
Wednesday
June 17, 2026
9:10 AM ET
BREYANZI® CAR T Cell Therapy Monitoring and Activity Updates Approved in Canada